Agreement between Rectosigmoidoscopy and Colonoscopy Analyses of Disease Activity and Healing in Patients with Ulcerative Colitis

Gastroenterology

Volumn 150, Issue 2, 2016, Pages 389-395.e3

  Colombel, Jean Frédéric ^a   Ordás, Ingrid ^b   Ullman, Thomas ^a   Rutgeerts, Paul ^c   Chai, Akiko ^d   O'Byrne, Sharon ^d   Lu, Timothy T ^d   Panés, Julián ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d GENENTECH INC   (United States)

Author keywords

Anti Integrin; EUCALYPTUS; IBD; Inflammatory Bowel Disease

Indexed keywords

ETROLIZUMAB; PLACEBO; GASTROINTESTINAL AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; COLONOSCOPY; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MAYO CLINIC ENDOSCOPIC SUBSCORE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGMOIDOSCOPY; STANDARD; ULCER HEALING; ULCERATIVE COLITIS; ULCERATIVE COLITIS ENDOSCOPIC INDEX OF SEVERITY; VIDEORECORDING; CLINICAL TRIAL; COLITIS, ULCERATIVE; COLON; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; PATHOLOGY; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WOUND HEALING;

ANTIBODIES, MONOCLONAL, HUMANIZED; COLITIS, ULCERATIVE; COLON; COLONOSCOPY; DOUBLE-BLIND METHOD; GASTROINTESTINAL AGENTS; HUMANS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; SIGMOIDOSCOPY; TREATMENT OUTCOME; VIDEO RECORDING; WOUND HEALING;

EID: 84959532442     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.10.016     Document Type: Article

References (22)

1. A. Kaser, S. Zeissig, and R.S. Blumberg Inflammatory bowel disease Annu Rev Immunol 28 2010 573 621
2. M.F. Neurath, and S.P.L. Travis Mucosal healing in inflammatory bowel diseases: a systematic review Gut 61 2012 1619 1635
3. A. Kornbluth, and D.B. Sachar The Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee Am J Gastroenterol 105 2010 501 523
4. A. Dignass, R. Eliakim, F. Magro, and et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 1: definitions and diagnosis J Crohns Colitis 6 2012 965 990
5. V. Annese, M. Daperno, M.D. Rutter, and et al. European evidence based consensus for endoscopy in inflammatory bowel disease J Crohns Colitis 7 2013 982 1018
6. P.I. Karecla, S.J. Bowden, S.J. Green, and et al. Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M290 beta 7 (alpha E beta 7) Eur J Immunol 25 1995 852 856
7. B.G. Feagan, G.R. Greenberg, G. Wild, and et al. Treatment of ulcerative colitis with a humanized antibody to the α4β7 integrin N Engl J Med 352 2005 2499 2507
8. K.L. Cepek, C.M. Parker, J.L. Madara, and et al. Integrin alpha E beta 7 mediates adhesion of T lymphocytes to epithelial cells J Immunol 150 1993 3459 3470
9. P.E. Hesterberg, D. Winsor-Hines, M.J. Briskin, and et al. Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7 Gastroenterology 111 1996 1373 1380
10. B.R. Ludviksson, W. Strober, R. Nishikomori, and et al. Administration of mAb against αEβ7 prevents and ameliorates immunization-induced colitis in IL-2-/- mice J Immunol 162 1999 4975 4982
11. W.J. Sandborn, J.F. Colombel, R. Enns, and et al. Natalizumab induction and maintenance therapy for Crohn's disease N Engl J Med 353 2005 1912 1925
12. D. Elewaut, N. Van Damme, F. De Keyser, and et al. Altered expression of alpha E beta 7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease Acta Gastroenterol Belg 61 1998 288 294
13. S. Vermeire, S. O'Byrne, M. Keir, and et al. Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial Lancet 384 2014 309 318
14. K.W. Schroeder, W.J. Tremaine, and D.M. Ilstrup Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study N Engl J Med 317 1987 1625 1629
15. S.P. Travis, D. Schnell, P. Krzeski, and et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) Gut 61 2012 535 542
16. S.P. Travis, D. Schnell, P. Krzeski, and et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity Gastroenterology 145 2013 987 995
17. C. Manginot, C. Baumann, and L. Peyrin-Biroulet An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitis Gut 64 2015 1181 1182
18. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
19. J. Kato, M. Kuriyama, S. Hiraoka, and et al. Is sigmoidoscopy sufficient for evaluating inflammatory status of ulcerative colitis patients? J Gastroenterol Hepatol 26 2011 683 687
20. R. Odze, D. Antonioli, M. Peppercorn, and et al. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis Am J Surg Pathol 17 1993 869 875
21. S.R. Rajwal, J.W. Puntis, P. McClean, and et al. Endoscopic rectal sparing in children with untreated ulcerative colitis J Pediatr Gastroenterol Nutr 38 2004 66 69
22. E.V. Loftus Jr., G.C. Harewood, C.G. Loftus, and et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis Gut 54 2005 91 96